Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
7 papers
Recent·Most cited
J. Lubow, L. M. Levoir, D. K. Ralph…·L. Goo
The paper uses single-cell transcriptomics to identify new broadly neutralizing antibodies against flaviviruses, including an IgA1 isotype with unique neutralizing properties.
E. C. Chen, P. Gilchuk, S. J. Zost…·J. E. Crowe
The paper analyzes the human antibody response to ebolavirus glycoprotein, identifying public clonotypes with neutralizing activity and implications for vaccine design.
K. J. Kramer, N. V. Johnson, A. R. Shiakolas…·I. S. Georgiev
This study identifies a potent SARS-CoV-2 antibody, 54042-4, that neutralizes variants of concern and has a unique epitope and genetic structure.
E. C. Chen, P. Gilchuk, S. J. Zost…·J. E. Crowe
The paper identifies public antibody clonotypes in SARS-CoV-2 convalescents and vaccinated individuals, revealing common epitope recognition and potential vaccine efficacy mechanisms.
S. Graham, H. A. Tu, B. D. McElvany…·A. J. Markmann
This study identifies a novel antigenic site on the Zika virus envelope glycoprotein targeted by a strongly neutralizing human monoclonal antibody, providing insights for vaccine design.
J. C. Whitbeck, A. Thomas, K. Kadash-Edmondson…·B. J. Doranz
This study validates ZIKV reporter virus particles (RVPs) as stable, reproducible, and antigenically identical to live virus for large-scale neutralization assays and vaccine development.
N. D. Durham, A. Agrawal, E. Waltari…·L. Goo
The paper identifies two broadly neutralizing antibodies against dengue virus through single B cell transcriptomics and characterizes their epitopes and evolutionary pathways.